Skip to main content
Caplight Logo









Throne Biotechnologies Inc.

Throne Biotechnologies Inc.

Private
Paramus, New JerseyHealthcare & Life Scienceshttps://www.thronebio.com/

Last Round

Crowdfunding

Jul 14, 2022

Est. Valuation

$120.04M

Total Funding Raised

$475,006

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Throne Biotechnologies Inc. is a biotechnology company that develops a disruptive stem cell technology, Stem Cell Educator therapy, to reverse autoimmune diseases like type 1 diabetes and alopecia areata.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

Stem Cell Educator Therapyex vivo cell therapyautoimmune disease treatmentcell therapyType 1 Diabetes treatmentimmune system resetautologous cell therapyregenerative medicineAlopecia Areata treatmentimmunotherapycord blood stem cellsclinical-stage biotechdialysis-like treatmentRight to Try accessGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Throne Biotechnologies Inc. Comparables

Compare Throne Biotechnologies Inc. with similar companies based on industry and business-model similarity.

Throne Biotechnologies Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NextCell Pharma AB
74%
Sana Biotechnology
64%
Vertex Pharmaceuticals
64%

Throne Biotechnologies Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJul 14, 2022
Convertible DebtDec 31, 2021

Key People

Founding team and executive leadership

Yong Zhao

Founder And CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Monthly visitors increased 43% MoM.

  • Apr 18, 2026

    Monthly visitors increased 46% MoM, reaching 2.7K.

Throne Biotechnologies Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Throne Biotechnologies Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Throne Biotechnologies Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersParamus, New Jersey
Employee Range8
Year Founded2011
Last FundingJul 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?